# Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage

Study · id `cardio:ct-nct06760078` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06760078](<https://clinicaltrials.gov/study/NCT06760078>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06760078

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 532 participants.

## Technical summary

Registry record NCT06760078. Randomized; quadruple masking; primary purpose treatment. Start 2024-12-31 (anticipated); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 532 participants (planned count; ClinicalTrials.gov record NCT06760078, source copy `cardio:ctgov-nct06760078-2025-01-07`, retrieved 2026-10-26)
- Planned start: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT06760078, source copy `cardio:ctgov-nct06760078-2025-01-07`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06760078, source copy `cardio:ctgov-nct06760078-2025-01-07`, retrieved 2026-10-26)
- Completion: 2026-07-01 (anticipated) (ClinicalTrials.gov record NCT06760078, source copy `cardio:ctgov-nct06760078-2025-01-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06760078, source copy `cardio:ctgov-nct06760078-2025-01-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06760078-2025-01-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage
- Acronym: TIME-ICH
- Condition: Spontaneous Intracranial Hemorrhage
- Condition: Hypertension
- Intervention (Drug): intravenous tranexamic acid (TXA) infusion
- Intervention (Drug): Placebo
- Lead sponsor: Xuanwu Hospital, Beijing
- Lead sponsor class: OTHER
- Collaborator: Beijing Municipal Health Commission
- Collaborator class: OTHER\_GOV
- Collaborator: Capital Medical University
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Soochow University
- Collaborator class: OTHER
- Collaborator: Linyi People's Hospital
- Collaborator class: OTHER
- Collaborator: Peking University Care Luzhong Hospital
- Collaborator class: OTHER
- Collaborator: Wuzhou Red Cross Hospital
- Collaborator class: OTHER
- Collaborator: Yantai Penglai Traditional Chinese Medicine Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Hebei North University
- Collaborator class: OTHER
- Collaborator: Jiaozuo Tumor Hospital
- Collaborator class: UNKNOWN
- Collaborator: Hunan Provincial People's Hospital
- Collaborator class: OTHER
- Collaborator: The People's Hospital of Liaoning Province
- Collaborator class: OTHER
- Collaborator: The First People's Hospital of Qujing, Yunnan Province
- Collaborator class: UNKNOWN
- Collaborator: Huizhou Third People's Hospital, Guangzhou Medical University
- Collaborator class: OTHER
- Collaborator: Nanyang Nanshi Hospital
- Collaborator class: OTHER
- Collaborator: Xing'anmeng People's Hospital
- Collaborator class: UNKNOWN
- Collaborator: Beijing Aerospace Center Hospital
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)
- Registry lists this organization as a collaborator: Beijing Municipal Health Commission (`cardio:org-beijing-municipal-health-commission`)
- Registry lists this organization as a collaborator: Capital Medical University (`cardio:org-capital-medical-university`)
- Registry lists this organization as a collaborator: The First Affiliated Hospital of Soochow University (`cardio:org-the-first-affiliated-hospital-of-soochow-university`)
- Registry lists this organization as a collaborator: Linyi People's Hospital (`cardio:org-linyi-people-s-hospital`)
- Registry lists this organization as a collaborator: Nanyang Nanshi Hospital (`cardio:org-nanyang-nanshi-hospital`)

## Provenance

Content hash: 5dbf71bab134e309c18d96fc3f12ef2235ecad50f2722e191f063e57467decbe
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
